Related references
Note: Only part of the references are listed.Cognitive dysfunction: A growing link between diabetes and Alzheimer's disease
Kavya Jash et al.
DRUG DEVELOPMENT RESEARCH (2020)
Berberine mitigates cognitive decline in an Alzheimer's Disease Mouse Model by targeting both tau hyperphosphorylation and autophagic clearance
Ying Chen et al.
BIOMEDICINE & PHARMACOTHERAPY (2020)
Polyphyllin VII attenuated RANKL-induced osteoclast differentiation via inhibiting of TRAF6/c-Src/PI3K pathway and ROS production
Long Zhou et al.
BMC MUSCULOSKELETAL DISORDERS (2020)
Biological Signatures of Alzheimer's Disease
Poornima Sharma et al.
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2020)
Activating transcription factor 6 reduces Aβ1-42 and restores memory in Alzheimer's disease model mice
Yayun Du et al.
INTERNATIONAL JOURNAL OF NEUROSCIENCE (2020)
Diabetes as a risk factor for Alzheimer's disease in the Middle East and its shared pathological mediators
Richard L. Jayaraj et al.
SAUDI JOURNAL OF BIOLOGICAL SCIENCES (2020)
Polyphenols isolated from lychee seed inhibit Alzheimer's disease-associated Tau through improving insulin resistance via the IRS-1/PI3K/Akt/GSK-3β pathway
Rui Xiong et al.
JOURNAL OF ETHNOPHARMACOLOGY (2020)
Structure, enzymatic activities, glycation and therapeutic potential of human serum albumin: A natural cargo
Gulam Rabbani et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES (2019)
Ribosylation-Derived Advanced Glycation End Products Induce Tau Hyperphosphorylation Through Brain-Derived Neurotrophic Factor Reduction
Beibei Wu et al.
JOURNAL OF ALZHEIMERS DISEASE (2019)
The protective underlying mechanisms of Schisandrin on SH-SY5Y cell model of Alzheimer's disease
Zhi-Ying Zhao et al.
JOURNAL OF TOXICOLOGY AND ENVIRONMENTAL HEALTH-PART A-CURRENT ISSUES (2019)
Analysis of Learning and Memory Ability in an Alzheimer's Disease Mouse Model using the Morris Water Maze
Huiling Tian et al.
JOVE-JOURNAL OF VISUALIZED EXPERIMENTS (2019)
A Low-Therapeutic Dose of Lithium Inhibits GSK3 and Enhances Myoblast Fusion in C2C12 Cells
Nigel Kurgan et al.
CELLS (2019)
Cinnamaldehyde ameliorates STZ-induced rat diabetes through modulation of IRS1/PI3K/AKT2 pathway and AGEs/RAGE interaction
Marwa E. Abdelmageed et al.
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY (2019)
KCa3.1 deficiency attenuates neuroinflammation by regulating an astrocyte phenotype switch involving the PI3K/AKT/GSK3β pathway
Tianjiao Wei et al.
NEUROBIOLOGY OF DISEASE (2019)
ATP11B deficiency leads to impairment of hippocampal synaptic plasticity
Jiao Wang et al.
JOURNAL OF MOLECULAR CELL BIOLOGY (2019)
Alzheimer's disease
C. A. Lane et al.
EUROPEAN JOURNAL OF NEUROLOGY (2018)
Regenerative Glycosylation
Yashapal Singh et al.
JOURNAL OF ORGANIC CHEMISTRY (2018)
Diabetes mellitus and Alzheimer's disease: GSK-3β as a potential link
Ying Zhang et al.
BEHAVIOURAL BRAIN RESEARCH (2018)
RAGE mediates Aβ accumulation in a mouse model of Alzheimer's disease via modulation of β- and γ-secretase activity
Fang Fang et al.
HUMAN MOLECULAR GENETICS (2018)
Targeted inhibition of RAGE reduces amyloid-β influx across the blood-brain barrier and improves cognitive deficits in db/db mice
Hao Wang et al.
NEUROPHARMACOLOGY (2018)
Use of Peptides for the Management of Alzheimer's Disease: Diagnosis and Inhibition
Mohammad H. Baig et al.
FRONTIERS IN AGING NEUROSCIENCE (2018)
Berberine Alleviates Tau Hyperphosphorylation and Axonopathy-Associated with Diabetic Encephalopathy via Restoring PI3K/Akt/GSK3β Pathway
Shanshan Wang et al.
JOURNAL OF ALZHEIMERS DISEASE (2018)
Synthetic Fragments of Receptor for Advanced Glycation End Products Bind Beta-Amyloid 1-40 and Protect Primary Brain Cells From Beta-Amyloid Toxicity
Anna V. Kamynina et al.
FRONTIERS IN NEUROSCIENCE (2018)
Bidirectional interactions between diabetes and Alzheimer's disease
Mitsuru Shinohara et al.
NEUROCHEMISTRY INTERNATIONAL (2017)
Cognitive impairment and dementia: a new emerging complication of type 2 diabetes-The diabetologist's perspective
Rafael Simo et al.
ACTA DIABETOLOGICA (2017)
Role of RAGE in Alzheimer's Disease
Zhiyou Cai et al.
CELLULAR AND MOLECULAR NEUROBIOLOGY (2016)
The relationship between advanced glycation end products and ocular circulation in type 2 diabetes
Kazuki Hashimoto et al.
JOURNAL OF DIABETES AND ITS COMPLICATIONS (2016)
Chronic hyperglycemia induced via the heterozygous knockout of Pdx1 worsens neuropathological lesion in an Alzheimer mouse model
Chuang Guo et al.
SCIENTIFIC REPORTS (2016)
A1-42 oligomer-induced leakage in an invitro blood-brain barrier model is associated with up-regulation of RAGE and metalloproteinases, and down-regulation of tight junction scaffold proteins
Wenbin Wan et al.
JOURNAL OF NEUROCHEMISTRY (2015)
Advanced Glycation End Products: A Molecular Target for Vascular Complications in Diabetes
Sho-ichi Yamagishi et al.
MOLECULAR MEDICINE (2015)
Linking insulin with Alzheimer's disease: emergence as type III diabetes
Sara Ahmed et al.
NEUROLOGICAL SCIENCES (2015)
3-Deoxyglucosone: A Potential Glycating Agent Accountable for Structural Alteration in H3 Histone Protein through Generation of Different AGEs
Jalaluddin M. Ashraf et al.
PLOS ONE (2015)
Receptor for advanced glycation end-products in neurodegenerative diseases
Judyta Juranek et al.
REVIEWS IN THE NEUROSCIENCES (2015)
Glycation of H1 Histone by 3-Deoxyglucosone: Effects on Protein Structure and Generation of Different Advanced Glycation End Products
Jalaluddin Mohammad Ashraf et al.
PLOS ONE (2015)
Emerging links between type 2 diabetes and Alzheimer's disease
Gumpeny R. Sridhar et al.
WORLD JOURNAL OF DIABETES (2015)
Advanced Glycation End Products and Oxidative Stress in Type 2 Diabetes Mellitus
Kerstin Nowotny et al.
BIOMOLECULES (2015)
The role of advanced glycation end products in various types of neurodegenerative disease: a therapeutic approach
Parveen Salahuddin et al.
CELLULAR & MOLECULAR BIOLOGY LETTERS (2014)
Streptozotocin-induced diabetes increases amyloid plaque deposition in AD transgenic mice through modulating AGEs/RAGE/NF-κB pathway
Xu Wang et al.
INTERNATIONAL JOURNAL OF NEUROSCIENCE (2014)
Physicochemical Analysis of Structural Alteration and Advanced Glycation End Products Generation During Glycation of H2A Histone by 3-Deoxyglucosone
Jalaluddin M. Ashraf et al.
IUBMB LIFE (2014)
Advanced Glycation End Products and Diabetic Complications
Varun Parkash Singh et al.
KOREAN JOURNAL OF PHYSIOLOGY & PHARMACOLOGY (2014)
Clinical trial of an inhibitor of RAGE-Aβ interactions in Alzheimer disease
Douglas Galasko et al.
NEUROLOGY (2014)
Diabetes Mellitus and the Risk of Alzheimer's Disease: A Nationwide Population-Based Study
Chin-Chou Huang et al.
PLOS ONE (2014)
Interleukin-13/-4-Induced Oxidative Stress Contributes to Death of Hippocampal Neurons in Aβ1-42-Treated Hippocampus In Vivo
J. H. Nam et al.
ANTIOXIDANTS & REDOX SIGNALING (2012)
Is RAGE still a therapeutic target for Alzheimer's disease?
Richard J. Deane
FUTURE MEDICINAL CHEMISTRY (2012)
Advanced glycation end products and neurodegenerative diseases: Mechanisms and perspective
Jinlong Li et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2012)
Aβ-induced formation of autophagosomes is mediated by RAGE-CaMKKβ-AMPK signaling
Sung Min Son et al.
NEUROBIOLOGY OF AGING (2012)
AGEs induce Alzheimer-like tau pathology and memory deficit via RAGE-mediated GSK-3 activation
Xiao-Hong Li et al.
NEUROBIOLOGY OF AGING (2012)
Molecular mechanisms linking diabetes mellitus and Alzheimer disease: beta-amyloid peptide, insulin signaling, and neuronal function
Shuko Takeda et al.
MOLECULAR BIOSYSTEMS (2011)
miR-27 promotes human gastric cancer cell metastasis by inducing epithelial-to-mesenchymal transition
Ziping Zhang et al.
CANCER GENETICS (2011)
The sour side of neurodegenerative disorders: the effects of protein glycation
Hugo Vicente Miranda et al.
JOURNAL OF PATHOLOGY (2010)
Hyperglycemia and Glycation in Diabetic Complications
Anne Negre-Salvayre et al.
ANTIOXIDANTS & REDOX SIGNALING (2009)
The role of the cell surface LRP and soluble LRP in blood-brain barrier a clearance in Alzheimer's Disease
R. Deane et al.
CURRENT PHARMACEUTICAL DESIGN (2008)
Advanced glycation end-products (AGES) and heart failure: Pathophysiology and clinical implications
Jasper W. L. Hartog et al.
EUROPEAN JOURNAL OF HEART FAILURE (2007)
Role of the blood-brain barrier in the pathogenesis of Alzheimer's disease
Rashid Deane et al.
CURRENT ALZHEIMER RESEARCH (2007)
Advanced glycosylation end products in skin, serum, saliva and urine and its association with complications of patients with Type 2 diabetes mellitus
ME Garay-Sevilla et al.
JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION (2005)
Signal transduction pathways in mouse microglia N-11 cells activated by advanced glycation endproducts (AGEs)
S Dukic-Stefanovic et al.
JOURNAL OF NEUROCHEMISTRY (2003)
RAGE mediates amyloid-β peptide transport across the blood-brain barrier and accumulation in brain
R Deane et al.
NATURE MEDICINE (2003)
Diabetes mellitus and risk of Alzheimer's disease and dementia with stroke in a multiethnic cohort
JA Luchsinger et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2001)
Share Paper
